Busca


Filtros atuais:
Iniciar uma nova busca
Adicionar filtros:

Use filtros para refinar os resultados da pesquisa.


Resultados 1-10 de 19 (Tempo de busca: 0.001 Segundos).
Resultados em Itens:
Data de publicaçãoTítuloAutor(es)
2016Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaDE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA; URUN, YUKSEL; CAROL, HALLIE A.; André Poisl Fay; SIGNORETTI, SABINA; KWIATKOWSKI, DAVID J.; MCDERMOTT, DAVID F.; FREEDMAN, MATTHEW; POMERANTZ, MARK M.; CHOUEIRI, TONI K.
2015HER2 as a target in invasive urothelial carcinomaBELLMUNT, JOAQUIM; WERNER, LILLIAN; BAMIAS, ARISTOTLE; André Poisl Fay; PARK, RACHEL S.; RIESTER, MARKUS; SELVARAJAH, SHAMINI; BARLETTA, JUSTINE A.; BERMAN, DAVID M.; DE MUGA, SILVIA; SALIDO, MARTA; GALLARDO, ENRIQUE; ROJO, FEDERICO; GUANCIAL, ELIZABETH A.; BAMBURY, RICHARD; MULLANE, STEPHANIE A.; CHOUEIRI, TONI K.; LODA, MASSIMO; STACK, EDWARD; ROSENBERG, JONATHAN
2017Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trialsMOREIRA, RAPHAEL B.; Marcio Debiasi; FRANCINI, EDOARDO; NUZZO, PIER V.; DE VELASCO, GUILLERMO; MALUF, FERNANDO C.; André Poisl Fay; BELLMUNT, JOAQUIM; CHOUEIRI, TONI K.; SCHUTZ, FABIO A.
2015Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial TumorsBELLMUNT, JOAQUIM; WERNER, LILLIAN; LEOW, JEFFREY J.; MULLANE, STEPHANIE A.; André Poisl Fay; RIESTER, MARKUS; VAN HUMMELEN, PAUL; TAPLIN, MARY-ELLEN; CHOUEIRI, TONI K.; VAN ALLEN, ELIEZER; ROSENBERG, JONATHAN
2018Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials DatabaseAndré Poisl Fay; MCKAY, RANA R.; LIN, XUN; SIMANTOV, RONIT; CHOUEIRI, TONI K.
2018The Clinical Activity of PD-1/PD-L1 inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaMCKAY, RANA R.; BOSSÉ, DOMINICK; XIE, WANLING; WANKOWICZ, STEPHANIE A. M.; FLAIFEL, ABDALLAH; BRANDAO, RAPHAEL; LALANI, ALY-KHAN; MARTINI, DYLAN J; WEI, XIAO X; BRAUN, DAVID A; VAN ALLEN, ELIEZER M.; CASTELLANO, DANIEL; DE VELASCO, GUILLERMO; WELLS, J. CONNOR; HENG, DANIEL Y. C.; André Poisl Fay; SCHUTZ, FABIO A.; HSU, JOANN; PAL, SUMANTA KUMAR; LEE, JAE-LYUN; HSIEH, JAMES; HARSHMAN, LAUREN C.; SIGNORETTI, SABINA; MOTZER, ROBERT J.; FELDMAN, DARREN R.; CHOUEIRI, TONI K.
2019Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaNASSAR, AMIN H; HAMIEH, LANA; GRAY, KATHRYN P.; THORNER, AARON R.; André Poisl Fay; LASSETER, KATHRYN D; ABOU ALAIWI, SARAH; NUZZO, PIER VITALE; FLIPPOT, RONAN; KRAJEWSKI, KATHERINE M.; SIGNORETTI, SABINA; CHOUEIRI, TONI K.; KWIATKOWSKI, DAVID J.
2015Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial TumorsBELLMUNT, JOAQUIM; WERNER, LILLIAN; LEOW, JEFFREY J.; MULLANE, STEPHANIE A.; André Poisl Fay; RIESTER, MARKUS; VAN HUMMELEN, PAUL; TAPLIN, MARY-ELLEN; CHOUEIRI, TONI K.; VAN ALLEN, ELIEZER; ROSENBERG, JONATHAN
2015HER2 as a target in invasive urothelial carcinomaBELLMUNT, JOAQUIM; WERNER, LILLIAN; BAMIAS, ARISTOTLE; André Poisl Fay; PARK, RACHEL S.; RIESTER, MARKUS; SELVARAJAH, SHAMINI; BARLETTA, JUSTINE A.; BERMAN, DAVID M.; DE MUGA, SILVIA; SALIDO, MARTA; GALLARDO, ENRIQUE; ROJO, FEDERICO; GUANCIAL, ELIZABETH A.; BAMBURY, RICHARD; MULLANE, STEPHANIE A.; CHOUEIRI, TONI K.; LODA, MASSIMO; STACK, EDWARD; ROSENBERG, JONATHAN
2015Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinomaALBIGES, LAURENCE; André Poisl Fay; XIE, WANLING; KRAJEWSKI, KATHERINE; MCDERMOTT, DAVID F.; HENG, DANIEL Y.C.; DARIANE, CHARLES; DEVELASCO, GUILLERMO; LESTER, RENEE; ESCUDIER, BERNARD; CHOUEIRI, TONI K.